Fangzhou Wins Tencent Health ‘AI-Powered Future Award’ as MaaS Platform Drives AI Chronic Care

Fangzhou Inc., a prominent player in AI-driven Internet healthcare solutions, has recently been honored with the prestigious “AI-Powered Future Award” at a high-profile industry forum hosted by Tencent Health. This accolade underscores Fangzhou’s leadership in integrating artificial intelligence into chronic care management, a rapidly evolving sector within China’s healthcare landscape.

As one of China’s foremost AI-enabled chronic care platforms, Fangzhou has strategically positioned technology at the heart of its growth and innovation. In 2025, the company completed a significant upgrade of its Hospital-to-Home (H2H) service model, enhancing its ability to provide continuous, personalized care to patients with chronic conditions. This upgrade reflects Fangzhou’s commitment to leveraging AI to bridge the gap between hospital treatment and home-based care, ensuring patients receive timely interventions and monitoring outside traditional clinical settings.

Fangzhou’s platform operates as a Mobility-as-a-Service (MaaS) solution tailored for healthcare, integrating AI algorithms that analyze patient data to optimize treatment plans and predict health risks. By harnessing big data and machine learning, the platform supports healthcare providers in delivering proactive, data-driven care, which is crucial for managing chronic diseases that require ongoing attention and adjustment.

The Tencent Health forum, where Fangzhou received its award, is a significant event that gathers industry leaders, innovators, and policymakers to discuss advancements in healthcare technology. Fangzhou’s recognition at this event highlights the broader trend of AI adoption in healthcare, particularly in chronic disease management, which poses substantial challenges due to its complexity and long-term nature.

The implications of Fangzhou’s achievements extend beyond its immediate business success. By demonstrating the viability and benefits of AI-powered chronic care, Fangzhou sets a benchmark for other healthcare providers and technology companies. This could accelerate the adoption of AI solutions across the healthcare sector, improving patient outcomes and reducing costs associated with chronic disease management.

Looking ahead, Fangzhou’s continued innovation in AI-driven healthcare services is expected to contribute significantly to the modernization of China’s healthcare system. The company’s approach exemplifies how technology can enhance patient engagement, streamline care delivery, and support healthcare professionals in making informed decisions. As chronic diseases remain a leading cause of morbidity worldwide, Fangzhou’s model offers a scalable and effective framework for integrating AI into everyday healthcare practices.